One month old, no product: DeepMind spinout Emulate in talks for $700 million at $3.7 billion

Index and Lightspeed are poised to lead up to $700 million into a company incorporated in August, with no product, no website and no disclosed headcount. The precedent for pricing nothing is Safe Superintelligence: two years, roughly $8 billion raised, a $32 billion valuation, and not one shipped model.

Vincent JiangVincent JiangSeptember 19, 2026 · 3 min read
Share
Demis Hassabis, cofounder of Google DeepMind, speaking at the 2024 Nobel Prize events in a dark suit and headset microphone against a black background.
Demis Hassabis at the 2024 Nobel Prize lectures. His August move from DeepMind chief executive to chair tracks a run of 112 alumni founding companies, Emulate the latest to price on pedigree alone.

Talks at $3.7 billion, one month in

Three researchers left Google DeepMind this summer, incorporated in August, and are in talks to be valued at $3.7 billion including the new capital 123. Index Ventures and Lightspeed are poised to jointly lead up to $700 million, and the mark would land on the books of the limited partners behind those two funds 1. One tracker puts the round in the top 1% of nearly 11,000 comparable seed deals 1.

Jack Parker-Holder, Matthew McGill and Philip Ball helped build Genie, DeepMind's line that turns a short prompt into an interactive 3D world 14. None of the three has run a company, and Emulate has no product, no website and no disclosed headcount 1.

The year capital learned to price nothing

The precedent is Safe Superintelligence. By one account, Ilya Sutskever's lab has raised roughly $8 billion, including $2 billion this year at a $32 billion valuation, and has shipped nothing at all 5. On 27 July 2026 Nvidia announced a long-term partnership and an equity investment, reported at $5 billion but unsized in Nvidia's own release, an exposure Nvidia's shareholders carry either way 65.

Nvidia says access to its next-generation Vera Rubin systems will expand the lab's compute by an order of magnitude, granted after what the release calls rare access to closely guarded research 6. An investor's early-August claim that SSI's first model would ship that month expired with no release, no paper and no post 5. The company website still names one product: safe superintelligence itself 7.

Pedigree is the product

Emulate is the third UK DeepMind spinout this year at a nine- or ten-figure price, after Ineffable Intelligence ($1 billion raised, $5 billion valuation) and Recursive Superintelligence ($600 million, $4 billion) 1. Evertrace counts 112 DeepMind alumni starting companies in 18 months, a run that tracks Demis Hassabis stepping from chief executive to chair in August 12.

The sequence suggests why the funds pay preemptively: with 112 alumni on the market, letting a rival own the team behind the next Genie costs more than the information a wait would buy. The product test survives elsewhere. World Labs, near-$5 billion on $1.23 billion raised, ships Marble and released its Atlas world model on 1 September 18. DeepMind still ships Genie 3 9.

What $3.7 billion has to become

Old seed arithmetic says a 10x on a $3.7 billion entry is a $37 billion outcome. The nearest price held without a shipped product is SSI's $32 billion 5. It took Sutskever's name, two years and roughly $8 billion to hold that mark, and that is the bar three first-time founders now carry 5.

Safe Superintelligence
$32B
Ineffable Intelligence
$5B
Recursive Superintelligence
$4B
Emulate (in talks)
$3.7B
Valuations in Emulate's cohort: the no-product precedent towers over the rest, and Emulate's bar is a price in talks, not a closed round.1,5

The tell

Watch two readings: whether Emulate's round closes at these terms, and whether SSI's tenfold compute ever becomes a model someone outside the deal can run 65. Emulate's price in talks now sets the comp for the rest of the 112 1. The bid is for the résumé; the bill goes to the limited partners.

How this brief was made

Become a contributor

Reporting on the business of AI and want it read? We take pitches from outside contributors who bring primary sources and a number worth arguing about.

Share

Deepdive

AI-generated from this story and its cited sources. Not investment advice.

Reader comments

0 comments

    Sign up

    Get your curated digest

    After email confirmation, you will receive a daily digest of the most relevant news that matter to your portfolio